FGF21-dependent alleviation of cholestasis-induced liver fibrosis by sodium butyrate.
Saved in:
| Title: | FGF21-dependent alleviation of cholestasis-induced liver fibrosis by sodium butyrate. |
|---|---|
| Authors: | Yang J; Institute of Life Sciences, China Medical University, Shenyang, China., Chen L; Institute of Life Sciences, China Medical University, Shenyang, China., Zhao SS; Institute of Life Sciences, China Medical University, Shenyang, China., Du C; Institute of Life Sciences, China Medical University, Shenyang, China., Fan YZ; Institute of Life Sciences, China Medical University, Shenyang, China., Liu HX; Institute of Life Sciences, China Medical University, Shenyang, China., Li Y; The Sixth Affiliated Hospital of South China University of Technology, Foshan, Guangdong, China., Li YZ; Department of Urology, The Fourth Affiliated Hospital of China Medical University, Shenyang, Liaoning, China.; Liaoning Key Laboratory of Bladder Disease Gene Research, Institute of Health Science, China Medical University, Shenyang, China. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2024 Jul 08; Vol. 15, pp. 1422770. Date of Electronic Publication: 2024 Jul 08 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
